Independent prognostic impact of tumour‐infiltrating macrophages in early‐stage Hodgkin's lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2295
Abstract: Although patients with early‐stage Hodgkin's lymphoma have a high rate of cure, a portion of these are resistant to or relapse after standard treatment. Current prognostic criteria based on clinical and laboratory parameters at diagnosis… read more here.
Keywords: stage hodgkin; infiltrating macrophages; hodgkin lymphoma; early stage ... See more keywords
Chemotherapy or combined modality therapy for early‐stage Hodgkin lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "Hematological Oncology"
DOI: 10.1002/hon.2439_54
Abstract: BACKGROUND/AIM Optimizing treatment of early-stage Hodgkin lymphoma (HL) requires balancing cure with potential acute and late toxicities from treatment. We reviewed our institutional experience with chemotherapy alone (ChT) versus combined modality therapy (CMT). MATERIALS AND… read more here.
Keywords: therapy; hodgkin lymphoma; stage hodgkin; early stage ... See more keywords
[Response to ABVD chemotherapeutic protocol in patients with early stage Hodgkins lymphoma].
Sign Up to like & getrecommendations! Published in 2017 at "Revista medica de Chile"
DOI: 10.4067/s0034-98872017000500009
Abstract: BACKGROUND Recent trials show that > 90% of patients with early stage Hodgkin`s Lymphoma (ESHL) can be cured, especially when using the ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapeutic (CT) protocol. The use of radiotherapy… read more here.
Keywords: patients early; hodgkin lymphoma; stage hodgkin; protocol ... See more keywords